Intermittent Fasting and CLL/SLL

Clinical trial NCT04626843 · COMPLETED

Trial details

NCT number: NCT04626843
Sponsor: Eleah Stringer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Leukemia, Lymphocytic, Chronic Lymphoma, Small Lymphocytic Intermittent Fasting Diet Habit Inflammation

Start date: 2021-02-03
Primary completion: 2022-10-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.